Monopar Therapeutics Inc (MNPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,737 | 13,214 | 6,893 | 8,982 | N/A |
| Other current assets | 63 | 16 | 359 | 0 | 0 |
| TOTAL | $16,800 | $13,230 | $7,252 | $9,131 | $N/A |
| Non-Current Assets | |||||
| Other Non-Current Assets | 69 | 122 | 66 | 800 | 0 |
| TOTAL | $69 | $122 | $66 | $800 | $N/A |
| Total Assets | $16,869 | $13,352 | $7,318 | $9,931 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,177 | 724 | 400 | 312 | 0 |
| TOTAL | $1,177 | $724 | $400 | $312 | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,177 | $724 | $400 | $312 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,513 | 2,124 | N/A | N/A | N/A |
| Common Shares | 12 | 11 | 9 | 9 | N/A |
| Retained earnings | -32,185 | -25,881 | -21,656 | -18,428 | N/A |
| Other shareholders' equity | -8 | -11 | -2 | 0 | 0 |
| TOTAL | $15,692 | $12,628 | $6,918 | $9,619 | $N/A |
| Total Liabilities And Equity | $16,869 | $13,352 | $7,318 | $9,931 | $0 |